This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
The Cooper Companies Inc (COO), based in Pleasanton, CA, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision (CVI) and CooperSurgical (CSI). CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company’s products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness. CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. This strategic business unit has pursued a strategy of consolidation by acquiring critical treatment niches in a fragmented market.
Here's Why You Should Retain Cooper Companies (COO) Stock
by Zacks Equity Research
Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across segments and prudent acquisitions. However, forex volatility remains a concern.
Cerner and naviHealth Extend Partnership, Boost EHR Service
by Zacks Equity Research
Cerner (CERN) and naviHealth coordinate to provide EHR offering that is expected to benefit health care providers in the form of affordable and accessible health care centered on the patient.
Here's Why You Should Bet on Cooper Companies (COO) Stock Now
by Zacks Equity Research
Cooper Companies (COO) is gaining traction from expansion in international markets, robust product portfolio across its segments and prudent acquisitions.
BD Introduces New Product to Reduce the Risk of Sepsis
by Zacks Equity Research
BD introduces new FDA cleared product to lower the risk of sepsis and combat platelet contamination.
Cooper Cos. (COO) Up 5.1% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Cooper Cos. (COO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Cooper Companies' (COO) CooperVision Gains Momentum Globally
by Zacks Equity Research
Cooper Companies (COO) maintains its leading position in the markets of specialty lenses, supported by highly exclusive products like Biofinity and Clariti.
Here's Why Investors Should Bet on Cooper Companies (COO) Now
by Zacks Equity Research
Cooper Companies (COO) maintains its leading position in the markets of specialty lenses. Further, the company exits first-quarter fiscal 2019 on a strong note.
Cooper Companies (COO) Hits 52-Week High on Solid Prospects
by Zacks Equity Research
Cooper Companies' (COO) revenues across CooperVision and CooperSurgery see growth.
What's in Store for Coupa Software (COUP) in Q4 Earnings?
by Zacks Equity Research
Coupa Software (COUP) benefits from expanding customer base. Further, rising adoption of the company's platform is driving subscription services revenues and gross margin.
Cooper Companies' (COO) Q1 Earnings Beat, Revenues Rise Y/Y
by Zacks Equity Research
Strong performance by Cooper Companies' (COO) CSI and CVI segments drove the top line in first-quarter fiscal 2019.
Can Segmental Growth Aid Cooper Companies' (COO) Q1 Earnings?
by Zacks Equity Research
Management at Cooper Companies (COO) expects solid contributions from CVI and CSI units.
Guidewire (GWRE) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Guidewire (GWRE) benefits from strong adoption of several cloud-based products.
Will R&D Focus Fuel DENTSPLY SIRONA's (XRAY) Earnings in Q4?
by Zacks Equity Research
DENTSPLY SIRONA's (XRAY) overall growth strategy depends on product innovation and R&D focus, which is likely to drive the top line in Q4.
Weight Watchers (WTW) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Weight Watchers' (WTW) core Product Sales unit is expected to put up a soft show in fourth-quarter 2018.
Why Is Cooper Cos. (COO) Down 11.1% Since Last Earnings Report?
by Zacks Equity Research
Cooper Cos. (COO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Hold Cooper Companies (COO) Stock Now
by Zacks Equity Research
Cooper Companies' (COO) strong CVI segment favors the stock while a soft Fertility unit raises concern.
Stock Market News For Dec 7, 2018
by Zacks Equity Research
U.S. stock markets closed mostly lower on Thursday as arrest of Chinese tech-behemoth Huawei's CFO in Canada significantly dented investors' hope of a solution to trade-related concerns
Cooper Companies (COO) Earnings Miss & Revenues Beat in Q4
by Zacks Equity Research
Cooper Companies (COO) gains from solid segmental performance in fiscal Q4.
Cooper Cos. (COO) Q4 Earnings Lag Estimates
by Zacks Equity Research
Cooper Cos. (COO) delivered earnings and revenue surprises of -3.04% and 0.88%, respectively, for the quarter ended October 2018. Do the numbers hold clues to what lies ahead for the stock?
Can CVI Segment Drive Cooper Companies' (COO) Q4 Earnings?
by Zacks Equity Research
Cooper Companies (COO) is likely to gain from strong segmental show in Q4. An upbeat guidance for the quarter raises optimism.
Greif (GEF) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Greif's (GEF) fourth-quarter fiscal 2018 results are likely to be supported by favorable price-cost relationship despite elevated transportation costs.
Cooper Cos. (COO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Cooper Cos. (COO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zscaler (ZS) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Zscaler (ZS) first-quarter fiscal 2019 results are expected to benefit from robust portfolio strength and customer wins but increasing expenses remain an overhang.
Coupa (COUP) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Coupa (COUP) to benefit from expanding customer base on the back of growing adoption of spend management platform
Smartsheet (SMAR) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Smartsheet's (SMAR) third-quarter fiscal 2019 results are expected to benefit from product enhancements and customer wins but increasing expenses remain a concern.